Dual oral antiplatelet therapy and unplanned surgery: Possible role for intravenous platelet glycoprotein receptor inhibitors

Journal of Cardiovascular Medicine

Volumn 12, Issue 9, 2011, Pages 673-674

  Bollati, Mario ^a   Giraudi, Elena ^a   Moretti, Claudio ^a   Millesimo, Giorgio ^a   Sciuto, Filippo ^a   Omedè, Pierluigi ^a   Biondi Zoccai, Giuseppe ^a   Sheiban, Imad ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

clopidogrel; stent; tirofiban

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; TIROFIBAN;

AGED; ANGIOCARDIOGRAPHY; BLEEDING; CASE REPORT; CHOLANGITIS; COMMON BILE DUCT STONE; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; LETTER; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESCRIPTION; STENT THROMBOSIS;

ADMINISTRATION, ORAL; AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; BILIARY TRACT SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; CHOLANGITIS; CHOLEDOCHOLITHIASIS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; TICLOPIDINE; TREATMENT OUTCOME; TYROSINE;

EID: 80051759169     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328339d89a     Document Type: Letter

References (18)

1. Smith SC Jr, Fredman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guidelines update for percutaneous coronary interventions: a report of American College of Cardiology/American Heart Association Task Force of Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Interventions). Circulation 2006; 113:156-175. (Pubitemid 43958502)
2. Roy P, Bonello L, Torguson R, et al. Temporal relation between clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol 2009; 103:801-805.
3. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297:159-168. (Pubitemid 46089732)
4. Joner M, Finn AV, Farb A, et al. Pathology of drug eluting stents in humans: delayed healing and late thrombosis risk. J Am Coll Cardiol 2006; 48:193-202. (Pubitemid 43929240)
5. Kotani J, Nanto S, Morozumi T. Angioscopic findings of the neo-intimal coverage over the sirolimus-eluting stent: nine months follow up study. J Am Coll Cardiol 2006; 47 (Suppl B):27B.
6. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130. (Pubitemid 40617065)
7. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with Representation from the American College of Physicians. Circulation 2007; 115:813-818. (Pubitemid 46294748)
8. Augoustides JGT. Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade. Anesthesiology 2007; 107:516. (Pubitemid 47333870)
9. D'Urbano M, Barlocco F, Poli A, et al. Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy. J Cardiovasc Med 2008; 9:737-741.
10. Broad L, Lee T, Conroy M, et al. Successful management of patients with a drug-eluting coronary stent presenting for elective noncardiac surgery. Br J Anaesth 2007; 98:19-22. (Pubitemid 44896746)
11. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004; 109:1930-1932. (Pubitemid 38544480)
12. Mc Fadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 64:1519-1522.
13. Bradbury A, Adam D, Garrioch M, Brittenden J, Gillies T, Ruckley CV. Changes in platelet count, coagulation and fibrinogen associated with elective repair of asymptomatic abdominal aortic aneurysm and aortic reconstruction for occlusive disease. Eur J Vasc Endovasc Surg 1997; 13:375-380. (Pubitemid 27183014)
14. Nasser M, Kapeliovich M, Markiewicz W. Late thrombosis of sirolimuseluting stent following non cardiac surgery. Catheter Cardiovasc Interv 2005; 65:516-519. (Pubitemid 41060756)
15. Kaluza JL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of non cardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35:1288-1294. (Pubitemid 30206904)
16. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004; 63:141-145. (Pubitemid 39313402)
17. Collet JP, Montalescot G. Premature withdrawal and alternative therapies to dual oral antiplatelet therapy. Eur Heart J Suppl 2006; 8:G46-G52. (Pubitemid 44526986)
18. van't Hof AW, Valgimigli M. Defining the role of platelet glycoprotein receptor inhibitors in STEMI: focus of tirofiban. Drugs 2009; 69:85-100.